ConditionBrain & nerves

Neurofibromatosis

Neurofibromatosis is a group of genetic conditions that cause tumors to grow on nerves throughout the body. There are three types: NF1, the most common, which causes cafe-au-lait spots, freckling and skin neurofibromas; NF2-related schwannomatosis, which causes tumors on the hearing nerves; and other forms of schwannomatosis, which cause painful nerve tumors. Most tumors are benign, but they can cause pain, disfigurement, learning problems or hearing loss. Care focuses on regular monitoring and treating complications.

Also called: NF, NF1 (von Recklinghausen disease), NF2-related schwannomatosis, schwannomatosis

At a glance

Types
NF1 (about 1 in 3,000 births), NF2-related schwannomatosis (about 1 in 25,000), schwannomatosis (rare).
Cause
Changes in tumor suppressor genes (NF1, NF2, SMARCB1, LZTR1); half inherited, half new mutations.
NF1 signs
Cafe-au-lait spots, freckling in armpits or groin, neurofibromas, Lisch nodules, learning differences.
NF2 signs
Bilateral vestibular schwannomas causing hearing loss, tinnitus and balance problems.
Treatment
Monitoring; surgery; selumetinib or mirdametinib for plexiform neurofibromas; bevacizumab for NF2 tumors.

When to get help

See a doctor within a day or two

  • A neurofibroma that suddenly grows, becomes hard or causes persistent pain, or new weakness or numbness (possible malignant change)
  • Vision changes, bulging of one eye, or early puberty in a child with NF1 (possible optic glioma)
  • Severe headaches, high blood pressure with palpitations and sweating (possible pheochromocytoma)
  • Sudden hearing loss, worsening balance or facial weakness in NF2

Book a routine appointment

  • Six or more cafe-au-lait spots in a child
  • Learning, attention or behavior difficulties in a child with NF1
  • Curvature of the spine or bowing of a lower leg
  • Annual review with an NF specialist or clinic

Types of neurofibromatosis

FeatureNF1NF2-related schwannomatosisSchwannomatosis (other)
GeneNF1 (chromosome 17)NF2 (chromosome 22)SMARCB1, LZTR1 and others
Main tumorsNeurofibromasVestibular schwannomas, meningiomas, ependymomasSchwannomas on peripheral and spinal nerves
HallmarkCafe-au-lait spots, frecklingBilateral hearing nerve tumorsChronic pain
Typical onsetChildhoodTeens to young adulthoodAdulthood

All are autosomal dominant: a parent with the condition has a 50% chance of passing it to each child. About half of people with NF1 have a new (spontaneous) gene change.

Neurofibromatosis type 1 (NF1)

Diagnostic features

NF1 is diagnosed when 2 or more of these are present (or 1 with a parent who has NF1):

  • 6 or more cafe-au-lait spots (over 5 mm before puberty, over 15 mm after)
  • freckling in the armpits or groin
  • 2 or more cutaneous neurofibromas, or 1 plexiform neurofibroma
  • optic pathway glioma
  • 2 or more Lisch nodules (harmless spots on the iris) or choroidal abnormalities
  • distinctive bone changes, such as bowing of the shin bone or sphenoid wing dysplasia
  • a pathogenic NF1 gene variant

Other features

  • learning disabilities and ADHD in about half of children
  • short stature and large head size
  • scoliosis
  • high blood pressure, sometimes from renal artery narrowing or pheochromocytoma
  • higher risk of certain cancers: malignant peripheral nerve sheath tumor (MPNST), breast cancer in women under 50, gliomas, GIST, leukemia in children
  • bilateral vestibular schwannomas (acoustic neuromas), causing gradual hearing loss, ringing in the ears and balance problems
  • meningiomas of the brain and spine
  • spinal tumors causing weakness or numbness
  • early cataracts
  • skin schwannomas

Schwannomatosis

Multiple schwannomas on spinal and peripheral nerves, usually without vestibular tumors. The main symptom is chronic, sometimes severe, pain.

Diagnosis

  • clinical examination of the skin, eyes, spine and nervous system
  • genetic testing of blood, or of tumor tissue in some cases
  • eye exams in children with NF1 yearly to detect optic gliomas
  • MRI of the brain and spine when symptoms suggest tumors, and regularly in NF2
  • hearing tests in NF2
  • whole-body MRI in some centers to measure tumor burden

Treatment

There is no cure, but treatment addresses symptoms and complications.

NF1

  • Monitoring: yearly checkups with skin, eye, blood pressure, growth, development and spine reviews.
  • Plexiform neurofibromas: MEK inhibitors such as selumetinib (approved for children) and mirdametinib (approved for children and adults) can shrink inoperable tumors. Surgery for selected tumors.
  • Cutaneous neurofibromas: removal by surgery or laser if painful or bothersome.
  • Optic gliomas: observation; chemotherapy if vision declines.
  • Learning support: early educational assessment, individualized education plans, ADHD treatment.
  • Cancer surveillance: for example, earlier breast cancer screening in women with NF1.
  • Malignant peripheral nerve sheath tumors: surgery, radiation and chemotherapy.
  • MRI monitoring of tumors
  • surgery or stereotactic radiosurgery for growing tumors
  • bevacizumab to shrink vestibular schwannomas and preserve hearing in some patients
  • hearing aids, cochlear implants or auditory brainstem implants

Schwannomatosis

Pain management and surgical removal of painful tumors.

Outlook

Most people with NF1 live full lives, though life expectancy is somewhat reduced on average, mainly due to cancers and vascular problems. NF2 is more variable; outcomes are improving with earlier diagnosis and new treatments. Genetic counseling helps families understand inheritance and options.

Frequently asked questions

What are the first signs of neurofibromatosis?

In NF1, the first sign is usually multiple flat, light-brown cafe-au-lait spots on the skin, often present at birth or appearing in the first year. Freckling in the armpits or groin follows in early childhood. NF2 usually first appears as hearing loss or ringing in the ears in the teens or twenties.

Is neurofibromatosis cancer?

Neurofibromatosis is not cancer, and most of its tumors are benign. However, people with NF1 have a higher lifetime risk of certain cancers, including malignant peripheral nerve sheath tumors, breast cancer and gliomas, so regular monitoring is important.

How is neurofibromatosis inherited?

It is autosomal dominant: a person with NF has a 50% chance of passing it to each child. About half of cases arise from a new genetic change, so there may be no family history. Severity varies widely, even within a family.

Can neurofibromas be removed?

Yes. Skin neurofibromas can be removed by surgery or laser if they are painful, catch on clothing or are cosmetically troublesome, though new ones may appear. Plexiform neurofibromas are harder to remove; MEK inhibitor medicines can shrink them.

Sources

This guide was written from current patient and clinical guidance, including:

  • NINDS: Neurofibromatosis
  • Children's Tumor Foundation: Understanding NF
  • American Academy of Pediatrics: Health supervision for children with neurofibromatosis type 1
  • MedlinePlus Genetics: Neurofibromatosis type 1; NF2-related schwannomatosis
  • National Cancer Institute: Neurofibromatosis and selumetinib